Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes

18 Jul 2022

Abstract excerpt

Human leukocyte antigen G (HLA-G) is a potential checkpoint molecule that plays a key role in cervical carcinogenesis. The purpose of this study was to construct and validate a prognostic risk model to predict the overall survival (OS) of cervical cancer patients, providing a reference for individualized clinical treatment that may lead to better clinical outcomes. HLA-G-driven differentially expressed genes...

Topics

Join the communities discussing this publication.

Ovarian cancer diagnosis and treatment
Reproductive Biology and Fertility
Reproductive System and Pregnancy

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35924232
DOI: 10.3389/fimmu.2022.851622

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed GenesPMID 35924232Read ↗

Development and validation of an immune-related prognostic signature in cervical cancerSemantic proximity Read ↗

Development and Validation of an Immune-related Prognostic Signature in Cervical CancerSemantic proximity Read ↗

Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer PatientsSemantic proximity Read ↗

Identification of prognosis-related genes in the cervical cancer immune microenvironmentSemantic proximity Read ↗

Identification of an inflammatory response-related gene prognostic signature and immune microenvironment for cervical cancerSemantic proximity Read ↗

Development of a Novel Immune Infiltration-Based Gene Signature to Predict Prognosis and Immunotherapy Response of Patients With Cervical CancerSemantic proximity Read ↗

Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical CancerSemantic proximity Read ↗

Identification of Key Pathways and Establishment of a Seven-Gene Prognostic Signature in Cervical CancerSemantic proximity Read ↗

Identification of prognosis-related genes in the cervical cancer immune microenvironmentSemantic proximity Read ↗

Six-lncRNA Immune Prognostic Signature for Cervical CancerSemantic proximity Read ↗

A Five-Genes-Based Prognostic Signature for Cervical Cancer Overall Survival PredictionSemantic proximity Read ↗

Characterization of tumor microenvironment and tumor immunology based on the double-stranded RNA-binding protein related genes in cervical cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.